John Paulson CRISPR Therapeutics AG

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$19.6

Avg closing price
Price range
John Paulson Portfolio Stock Details (CRSP)

3 John Paulson CRISPR Therapeutics AG Trades

John Paulson started to build up the position in CRISPR Therapeutics AG in Q1 2017. Since then they sold 50.5 Thousand shares. The investor completely sold their stake between Q2 2017 and Q3 2017.

Avg closing price
Price range
Sold -28.5 Thousand shares Q3 2017
Avg closing price $18.13
Price range $15.78 - $20.66
Sold 43.6% shares (-22 Thousand shares) Q2 2017
Avg closing price $16.52
Price range $13.62 - $21.61
New holding (+50.5 Thousand shares) Q1 2017
Avg closing price $19.63
Price range $14.78 - $23.73
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.